✨ Medicine Approvals
NEW ZEALAND GAZETTE, No. 15
14 FEBRUARY 2013
Rebetol dose:
Active Ingredient: Ribavirin 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
- Schering-Plough Company, County Cork, Ireland
- Schering-Plough Products Inc, Las Piedras, Puerto Rico
- Schering-Plough (Singapore) Pte Limited, Singapore
- MSD International GmbH (Singapore Branch), Singapore
Product:
Victrelis® Pegatron® Combination Therapy (Combination Product)
Victrelis dose:
Active Ingredient: Boceprevir 200mg
Dosage Form: Capsule
PEG-Intron dose:
Active Ingredient: Peginterferon alfa-2b 100mcg
Dosage Form: Powder for injection with diluent
Rebetol dose:
Active Ingredient: Ribavirin 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
- Schering-Plough Company, County Cork, Ireland
- Schering-Plough Products Inc, Las Piedras, Puerto Rico
- Schering-Plough (Singapore) Pte Limited, Singapore
- MSD International GmbH (Singapore Branch), Singapore
Product:
Victrelis® Pegatron® Combination Therapy (Combination Product)
Victrelis dose:
Active Ingredient: Boceprevir 200mg
Dosage Form: Capsule
PEG-Intron dose:
Active Ingredient: Peginterferon alfa-2b 120mcg
Dosage Form: Powder for injection with diluent
Rebetol dose:
Active Ingredient: Ribavirin 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
- Schering-Plough Company, County Cork, Ireland
- Schering-Plough Products Inc, Las Piedras, Puerto Rico
- Schering-Plough (Singapore) Pte Limited, Singapore
- MSD International GmbH (Singapore Branch), Singapore
Product:
Victrelis® Pegatron® Combination Therapy (Combination Product)
Victrelis dose:
Active Ingredient: Boceprevir 200mg
Dosage Form: Capsule
PEG-Intron dose:
Active Ingredient: Peginterferon alfa-2b 150mcg
Dosage Form: Powder for injection with diluent
Rebetol dose:
Active Ingredient: Ribavirin 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
- Schering-Plough Company, County Cork, Ireland
- Schering-Plough Products Inc, Las Piedras, Puerto Rico
- Schering-Plough (Singapore) Pte Limited, Singapore
- MSD International GmbH (Singapore Branch), Singapore
Product:
Zoledronate-DRLA
Active Ingredient: Zoledronic acid monohydrate 0.0533mg/mL equivalent to zoledronic acid 0.05mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Gland Pharma Limited, Andhara Pradesh, India
Next Page →
✨ LLM interpretation of page content
🏥
Consent to Distribution of New Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines, Approval, Distribution, Rebetol, Victrelis, Pegatron, Zoledronate-DRLA
NZ Gazette 2013, No 15